Elixinol Wellness (ASX:EXL) Other Operating Expense: A$3.23 Mil (TTM As of Dec. 2025)


What is Elixinol Wellness Other Operating Expense?

Elixinol Wellness ASX:EXL Other Operating Expense is A$3.23 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

Elixinol Wellness's Other Operating Expense for the six months ended in Dec. 2025 was A$1.63 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$3.23 Mil.

Elixinol Wellness's quarterly Other Operating Expense increased from Dec. 2024 (A$1.44 Mil) to Jun. 2025 (A$1.60 Mil) and increased from Jun. 2025 (A$1.60 Mil) to Dec. 2025 (A$1.63 Mil).

Elixinol Wellness's annual Other Operating Expense increased from Dec. 2023 (A$1.90 Mil) to Dec. 2024 (A$2.88 Mil) and increased from Dec. 2024 (A$2.88 Mil) to Dec. 2025 (A$3.23 Mil).

Elixinol Wellness Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Elixinol Wellness's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixinol Wellness Other Operating Expense Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial 3.87 2.87 1.90 2.88 3.23

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 1.44 1.44 1.60 1.63

Elixinol Wellness Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$3.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of A$3.23 Mil mean?
Elixinol Wellness (ASX:EXL) has a Other Operating Expense of A$3.23 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Elixinol Wellness and its competitors.
Is Elixinol Wellness' Other Operating Expense too high?
Elixinol Wellness' current Other Operating Expense is A$3.23 Mil.
How does Elixinol Wellness' Other Operating Expense compare to ZTS and UTHR?
Elixinol Wellness' Other Operating Expense of A$3.23 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Elixinol Wellness and its competitors. Elixinol Wellness's current Other Operating Expense is A$3.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixinol Wellness stock overvalued right now?
Based on GuruFocus' analysis, Elixinol Wellness (ASX:EXL) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.01 — trading 70% below its estimated fair value. The current Other Operating Expense is A$3.23 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Elixinol Wellness (ASX:EXL), the current Other Operating Expense is A$3.23 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixinol Wellness Business Description

Other Exchanges ELLXF:USAE8M:Germany
Address 51 - 53 Riversdale Road, Newtown, VIC, AUS, 3220
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.